Disclosure: We may earn a commission if you sign up through some links on this site, at no extra cost to you. We do not accept payment for favorable reviews. Read our full affiliate disclosure.
Oak Longevity at a Glance
- What it is
- Genuinely cheap compounded GLP-1s — sold on a "no subscriptions" promise its own terms contradict, with the harshest no-refund clause we have read
- Medication type
- Compounded only
- Medications offered
- Compounded semaglutide injection
- Compounded tirzepatide injection (marketed as GLP-1/GIP)
- Non-injectable oral and sublingual GLP-1 formulations — drops or tablets
- Compounded B6 or B12 combinations "when appropriate"
- Pricing
- Advertised from $119/mo semaglutide and $185/mo tirzepatide — but the site publishes four different Oak prices
- Insurance
- None. Oak is cash-pay only, and its Terms state that Medicare and Medicaid do not cover its products and services and that it will not submit claims to them. Compounded medication is not covered by commercial insurance either.
- Date reviewed
- August 7, 2026
How we scored it
Scores follow the published rubric in our provider comparison methodology.
Medical Disclaimer
We're not doctors, and this review is not medical advice. GLP-1 medications are prescription-only and require evaluation by a licensed healthcare provider. What works for one person may not work for another, and only a clinician who knows your history can determine whether a medication is appropriate for you. See our full medical disclaimer.
What Is Oak Longevity?
Oak Longevity is a cash-pay compounded GLP-1 service operating in all 50 states, with no membership fee, free shipping, free health coaching and same-day approval. Its headline prices — semaglutide from $119/month, tirzepatide from $185/month — are at the low end of this market, and if they are what you actually pay, they are a good deal.
That "if" is the review. Oak publishes four different monthly figures for its own service across two pages of its own site. The homepage says "Semaglutide from $119" and "Tirzepatide from $185"; the comparison table on that same homepage puts Oak at $167/mo; the identical comparison table on the weight-loss page puts Oak at $190/mo. Independent reviewers report that the prices inside the enrolment funnel are higher again for a single month, with the advertised low numbers attached to longer prepaid terms. We could not reach the funnel pricing ourselves, so treat the checkout figure as the only one that counts.
The larger problem is a flat contradiction between the marketing and the contract. The homepage sells "One price · All dosages · No subscriptions". The Terms of Use say the opposite: "most of these prescriptions are configured as a subscription that will renew on a recurring basis", that Oak "will charge your form of payment on file", and that "Your Subscription fee may change from time to time based on changes in dosage, prescription or form of product". Those two statements cannot both be true.
And then the refund clause, which is the most absolute we have read anywhere in this market. Once a provider approves and prescribes and the order reaches the pharmacy, Oak states the order "can no longer be cancelled and is non-refundable... even if you cancel your account or subscription after approval, and even if you attempt to stop, hold, reroute, return, or cancel the shipment directly with FedEx (or any other carrier) or with the pharmacy or fulfiller". Read that alongside "No video call required. Get approved online today" and same-day approval, and the window between paying and being permanently committed is measured in hours.
How the Program Works
- Consultation process
- An online health questionnaire reviewed by a licensed provider. Oak advertises "No video call required. Get approved online today" and same-day approval. There is no synchronous consultation in the standard path.
- Eligibility
- Oak lists its exclusions plainly: under 18, currently pregnant or nursing, or BMI under 22 with no prior comorbidities. It says providers review your health profile to determine whether treatment is appropriate. A BMI floor of 22 is markedly lower than the FDA-approved indications for the brand-name products, which start at BMI 30, or 27 with a weight-related condition.
- Provider involvement
- Oak describes prescriptions as written by "obesity-certified doctors" and reviewed by board-certified providers, and offers free access to an Oak Care Team plus free health coaching. It does not name the medical group, the prescribing physicians, or publish their credentials. Its Terms state plainly that "OAK DOES NOT PROVIDE HEALTHCARE SERVICES" and that it is a facilitator contracting with providers.
- Lab requirements
- Not published. Oak does not state whether bloodwork is required before or during treatment. Its Terms reference contracted lab test providers, so testing exists as a service, but nothing tells you whether it applies to you or what it costs.
- Pharmacy fulfillment
- Not named. Oak says prescriptions are "fulfilled through licensed U.S. compounding pharmacies that comply with state and federal pharmacy regulations" but does not identify them or state whether they are 503A pharmacies or 503B outsourcing facilities. Its Terms confirm that "neither Oak nor any Provider will accept return of these custom compounded products."
- Shipping frequency
- Free shipping, advertised as same-day dispatch with tracking, arriving "in days". Refills renew on a recurring basis per the Terms. Orders already paid and within 48 hours of shipment go out regardless of cancellation.
- Support services
- Free health coaching, free Oak Care Team access, an online refill flow, and a weight-loss calculator. Oak advertises a 4.6 rating and support in English and Spanish.
Oak Longevity Pricing
- Membership fee
- None. Oak is explicit that there is no membership fee, and its comparison table contrasts that with the $50–$99/month it attributes to other telehealth services.
- Medication fee
- Homepage: semaglutide "As low as $119 /mo", tirzepatide "As low as $185 /mo", with a "$200 off" new patient offer and a summer sale claiming "Save up to 60% vs. retail pricing". The homepage comparison table lists Oak at $167/mo. The weight-loss page comparison table lists Oak at $190/mo. Independent reviewers report meaningfully higher prices for one-month plans inside the funnel.
- Cancellation policy
- You can cancel in your account at any time, and Oak says cancellation takes effect on a best-efforts basis, aiming within 24 hours. But any refills or orders already paid and within 48 hours of shipment will still be sent, with cancellation taking effect only after that shipment.
- Refund policy
- The strictest we have seen. Oak states that once a provider has approved and prescribed your treatment and the order has reached its pharmacy or fulfilment partner, the order "can no longer be cancelled and is non-refundable... even if you attempt to stop, hold, reroute, return, or cancel the shipment directly with FedEx (or any other carrier) or with the pharmacy or fulfiller". Combined with same-day approval and no video call, that leaves a very short window in which you can change your mind. Disputes are subject to binding arbitration.
- Insurance
- None. Oak is cash-pay only, and its Terms state that Medicare and Medicaid do not cover its products and services and that it will not submit claims to them. Compounded medication is not covered by commercial insurance either.
- HSA / FSA
- Not addressed by Oak. Prescription medication costs are commonly HSA/FSA-eligible; confirm with your administrator, and note that compounded medication reimbursement is not guaranteed.
Pricing details worth knowing
- Four different Oak monthly prices appear across two pages of Oak's own site: $119, $167, $185 and $190. Get your figure at checkout.
- "No subscriptions" appears on the homepage. The Terms of Use describe recurring subscription billing with a card on file. Believe the Terms.
- The Terms also state your subscription fee "may change from time to time based on changes in dosage, prescription or form of product" — which is difficult to reconcile with "One price · All dosages".
- The $200 new-patient discount and the "up to 60% off retail" framing are promotional; the recurring rate is what matters.
- Oak's comparison table attributes $1,000–$1,400/month to brand-name medication. Novo Nordisk sells Wegovy direct at $199/month and Eli Lilly sells Zepbound self-pay from $299/month, so that comparison is well out of date.
Prices change. Every figure above was taken from Oak Longevity's published pages or the named sources at the bottom of this review, as of August 7, 2026. Telehealth pricing in this market changes frequently, and promotional rates expire. Confirm your actual cost at checkout before enrolling.
Pros and Cons
Pros
- Genuinely low advertised pricing — $119/mo semaglutide and $185/mo tirzepatide are at the bottom of this market
- No membership fee, so there is no second number to add
- Free shipping and free health coaching included
- Operates in all 50 states, with Spanish-language support
- Publishes its exclusions plainly — under 18, pregnant or nursing, BMI under 22 without comorbidities
- Oral and sublingual formats available as well as injections
- Terms of Use are detailed and specific rather than boilerplate — which is how we can tell you what is in them
Cons
- Four different Oak monthly prices across two pages of its own site
- "No subscriptions" on the homepage is contradicted by recurring-billing language in its own Terms
- Once approved, orders are non-refundable — explicitly including attempts to stop the shipment with the carrier
- Same-day approval with no video call means the commitment window is very short
- Does not name its compounding pharmacies or say whether they are 503A or 503B
- Does not publish lab requirements or name the prescribing medical group
- Three different corporate names appear in the same Terms document
- Answers "Is compounded medication safe?" with an unqualified "Yes"
- Disputes go to binding arbitration
Who Oak Longevity May Be Best For
Cash-pay patients who have already decided on compounded medication, want the lowest price, and will read the checkout page carefully before confirming
People who want an oral or sublingual option rather than an injection
Spanish-speaking patients, since Oak supports Spanish
Limitations
Do not buy on the advertised price. Four different figures appear on Oak's own site and the funnel is reported to be higher for one-month plans. Screenshot your checkout total.
Assume you are on a subscription. The homepage says otherwise; the contract you agree to says you are. Set a calendar reminder before the renewal date.
Understand that approval is the point of no return. There is no cooling-off period after a provider approves your order, and Oak has written that clause to survive a carrier intercept.
Ask which pharmacy compounds your medication and whether it is 503A or 503B before you pay, not after.
Note what else this operator sells. Oak's own Terms state they cover "all brands operated by Oak Longevity Holdings Corp., including Oak Longevity, RetaClinic, and Flow Longevity". RetaClinic markets retatrutide, an investigational Eli Lilly compound that is not approved by the FDA, has no USP monograph and is not on the FDA's bulk substance lists — which means there is no lawful route to compound it under section 503A or 503B. That is a materially more aggressive regulatory posture than selling compounded semaglutide.
Oak states its compounded products contain "the same active ingredient as their brand-name counterparts". "Same active ingredient" claims are among those the FDA cited in its June 2026 warning letters to 25 telehealth companies. We found no evidence Oak has received one, but it is the kind of claim currently under enforcement scrutiny.
About Compounded GLP-1s
The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025, which ended the window for compounding pharmacies to make large volumes of copies of those drugs (503A pharmacies had until April 22, 2025; 503B outsourcing facilities until May 22, 2025). Many telehealth companies continue to offer compounded GLP-1s prescribed for an individual patient — often as a personalized dose, a microdose, or a formulation combined with a vitamin such as B12 or B6. That practice sits in a contested legal area, and the FDA has continued to act. In a Federal Register notice published on May 1, 2026, the FDA proposed not to include semaglutide, tirzepatide or liraglutide on the 503B bulks list, saying it had not identified sufficient evidence of a clinical need for outsourcing facilities to compound them from bulk substances; the comment period was extended to July 30, 2026. Separately, in February 2026 the FDA issued warning letters to 30 telehealth companies over false or misleading claims about compounded GLP-1s, and it has continued: a further round dated 8 June 2026 — 25 warning letters, posted publicly on 16 June 2026 — reached companies including Medica Weight Loss, FITISH and Roen Health (RoenRx), again over false or misleading claims about compounded semaglutide and tirzepatide that the FDA said made the products misbranded under sections 502(a) and 502(bb) of the FD&C Act. The claims cited included suggesting the products were FDA-approved, implying equivalence to Ozempic, Wegovy, Mounjaro or Zepbound, and asserting the "same active ingredient" or "same results" as the approved drugs. Compounded medications are not FDA-approved, which means they have not gone through the same review as the brand-name products.
None of that is specific to Oak Longevity — it applies to every provider offering compounded medication. We cover the trade-offs in detail in our guide to brand-name versus compounded GLP-1s.
Alternatives to Oak Longevity
NovoCare Pharmacy
FDA-approved Wegovy direct at $149–$199/mo — no compounding questions, and cheaper than Oak's tirzepatide
Read review →Henry Meds
Compounded oral and sublingual options with clearer published policies
Read review →Ondra Health
The lowest compounded rate we could verify, at $96/mo on a 12-month plan
Read review →vs. CoreAge RX, our top-rated platform
Across the platforms we've reviewed, CoreAge RX remains our highest-rated option for cash-pay patients, with compounded semaglutide from $99/month and tirzepatide from $149/month including free two-day shipping. Whether it beats Oak Longevity for you depends on the things this review has covered — insurance, medication type, and how much support you actually want.
Frequently Asked Questions
How much does Oak Longevity actually cost?
We cannot tell you, and that is the finding. Oak's homepage advertises semaglutide "As low as $119 /mo" and tirzepatide "As low as $185 /mo". The comparison table further down that same page puts Oak at $167/mo. The identical table on Oak's weight-loss page puts it at $190/mo. Independent reviewers report the in-funnel price for a single month is higher still, with the advertised figures attached to longer prepaid terms. There is no membership fee and shipping is free, so whatever appears at checkout is the whole number — but check it before you confirm, because it is not the number on the homepage.
Does Oak really have no subscription?
Its homepage says "No subscriptions". Its Terms of Use say "most of these prescriptions are configured as a subscription that will renew on a recurring basis", that Oak will charge the card on file when a refill is due, and that "Your Subscription fee may change from time to time based on changes in dosage, prescription or form of product". The Terms are the document you are agreeing to. Assume recurring billing, and set a reminder before your renewal date.
Can I get a refund from Oak?
Almost certainly not, once a provider approves your order. Oak's policy states that after approval and dispatch to its pharmacy, the order "can no longer be cancelled and is non-refundable" and "no refund will be issued — even if you cancel your account or subscription after approval, and even if you attempt to stop, hold, reroute, return, or cancel the shipment directly with FedEx (or any other carrier) or with the pharmacy or fulfiller". That is unusually absolute, and it is written to close the loopholes people normally use. Since Oak also advertises same-day approval with no video call, the practical cooling-off period can be a few hours.
Is Oak Longevity legitimate?
It is a real, operating company with a named corporate entity, published Terms of Use dated 30 December 2025, a contact email and phone number, coverage in all 50 states, and a LegitScript verification link on its site. We found no evidence it has received an FDA warning letter. That is different from saying its disclosures are clean: three corporate names appear in the same Terms document, four different prices appear across two pages, the "no subscriptions" claim contradicts the contract, and no compounding pharmacy is named. Those are the things to weigh.
What is RetaClinic and why does it matter?
Oak's own Terms of Use state that they apply to "all brands operated by Oak Longevity Holdings Corp., including Oak Longevity, RetaClinic, and Flow Longevity". RetaClinic markets retatrutide. Retatrutide is an investigational Eli Lilly compound still in clinical trials — it is not FDA-approved, it is not a component of any approved drug, it has no USP monograph, and it does not appear on the FDA's bulk substance lists, which means there is no lawful pathway to compound it under section 503A or 503B. That tells you something about the operator's appetite for regulatory risk, even if it has no bearing on the semaglutide you might buy from Oak itself.
Is compounded medication from Oak safe?
Oak's FAQ answers this with an unqualified "Yes". We would not put it that way. Compounded medications are not FDA-approved, meaning they have not been evaluated by the FDA for safety, effectiveness or quality — that is true regardless of how good the pharmacy is. The honest answer is that a compounded product from a well-run licensed pharmacy prescribed by a real clinician can be reasonable for an individual patient, and that you are accepting a different level of regulatory assurance than with a brand-name product. Oak declining to name its pharmacies makes that harder to assess than it needs to be.
Who should not use Oak Longevity?
Anyone who wants an FDA-approved medication, or who might have insurance coverage. Anyone who needs the ability to change their mind after ordering. Anyone uncomfortable with binding arbitration. Separately, Oak's own exclusions are under 18, currently pregnant or nursing, and BMI under 22 without comorbidities — and GLP-1 medications are not appropriate if you have a personal or family history of medullary thyroid carcinoma or MEN 2, or if you have had pancreatitis. A licensed clinician who knows your history should decide.
The Verdict
Oak advertises compounded semaglutide from $119/month and tirzepatide from $185/month with no membership fee, free shipping and free health coaching, in all 50 states. Its own Terms of Use describe recurring subscription billing, and state that once a provider approves your order it is non-refundable even if you try to stop the shipment with the carrier.
Opens Oak Longevity's official site · Verify current pricing there
Compare Every Provider Side by Side
See how Oak Longevity stacks up against every platform we've reviewed on price, medication type, and what's actually included.
How We Researched This Review
We compiled this review on August 7, 2026 from Oak Longevity's own published pages plus independent reporting. We have not signed up for this service ourselves, and we say so rather than implying firsthand testing. Where Oak Longevity does not publish a detail — refund terms, lab requirements, pharmacy partners — we've said that plainly instead of guessing.
Sources
- oaklovesyou.com — homepage: "Semaglutide from $119", "Tirzepatide from $185", "One price · All dosages · No subscriptions", "$200 off — new patient offer", "SUMMER SALE — Save up to 60% vs. retail pricing", "Free Shipping", "Free Health Coaching"; comparison table listing Oak monthly cost at $167/mo against "$1,000-$1,400/mo" for brand-name meds and "$400-$500/mo" for other telehealth (checked August 7, 2026)
- oaklovesyou.com/weightloss — "No video call required. Get approved online today"; "GLP-1 weight loss medication prescribed by obesity-certified doctors. Always in stock"; compounded tirzepatide, compounded semaglutide and non-injectable oral/sublingual options with "compounded B6 or B12 options available when appropriate"; exclusions listed as under 18, pregnant or nursing, BMI under 22 with no prior comorbidities; comparison table listing Oak monthly cost at $190/mo (checked August 7, 2026)
- oaklovesyou.com/terms-of-use — effective 30 December 2025: "most of these prescriptions are configured as a subscription that will renew on a recurring basis"; "Your Subscription fee may change from time to time based on changes in dosage, prescription or form of product"; cancellation "on a best-efforts basis" aiming within 24 hours, with orders within 48 hours of shipment still sent
- oaklovesyou.com/terms-of-use — refund policy: once approved and sent to the pharmacy an order "can no longer be cancelled and is non-refundable... even if you cancel your account or subscription after approval, and even if you attempt to stop, hold, reroute, return, or cancel the shipment directly with FedEx (or any other carrier) or with the pharmacy or fulfiller"; disputes "resolved via Binding Arbitration"; Medicare and Medicaid not covered
- oaklovesyou.com/terms-of-use — "These Terms of Use apply to all brands operated by Oak Longevity Holdings Corp., including Oak Longevity, RetaClinic, and Flow Longevity"; the same document names the entity variously as "Oak Longevity Holdings Corp.", "Leaf Longevity Holdings Corp. DBA Oak Longevity" and "Oak Longevity Corp"
- oaklovesyou.com FAQ — "Is compounded medication safe? Yes"; prescriptions "fulfilled through licensed U.S. compounding pharmacies that comply with state and federal pharmacy regulations", with no pharmacy named and no 503A or 503B designation given
- retaclinic.com — marketed by the same operator, selling retatrutide protocols; retatrutide is an investigational Eli Lilly compound that is not FDA-approved, is not a component of any approved drug, has no USP monograph and does not appear on the FDA bulk substance lists, so there is no lawful pathway to compound it under section 503A or 503B (checked August 7, 2026)
Affiliate Disclosure: This review may contain affiliate links. If you click a link and sign up, we may receive a commission at no additional cost to you. We do not accept payment for favorable coverage, and commission relationships do not affect our scores. Read our full affiliate disclosure policy.